vimarsana.com
Home
Live Updates
The CMS List of Selected Drugs: Developing Effective Argumen
The CMS List of Selected Drugs: Developing Effective Argumen
The CMS List of Selected Drugs: Developing Effective Arguments for Pricing of Selected Drugs Under the Inflation Reduction Act of 2022 | BakerHostetler
On Aug. 29, the Centers for Medicare & Medicaid Services (“CMS”) issued the inaugural list of drugs selected for price setting under the Inflation Reduction Act of 2022 (IRA). Those...
Related Keywords
United States ,
Meena Seshamani ,
Medicare Drug Price Negotiation Program ,
Supreme Court ,
Centers For Medicare Medicaid Services ,
Bakerhostetler Drug Pricing Team ,
Human Services ,
Medicaid Services ,
Drug Pricing Team ,
Department Of Health ,
Inflation Reduction Act ,
Reduction Act ,
Revised Guidance ,
Social Security Act ,
Initial Price Applicability Year ,